About Eric Solien
Eric Solien is vice president of clinical sciences at Medical 21, a medical device company for coronary artery bypass surgery patients. He is one of the company's three founders, with Manny Villafaña and Chaid Schwarz. He has worked there since 2016, first as a senior research scientist. He became vice president in June 2025.
Solien is a preclinical surgeon. He has a particular interest in surgical revascularization strategies for the heart. His research looks at how heart devices are implanted and evaluated in large animal models. He has taken part in many privately funded studies of both interventional and surgically delivered devices. He has a biology degree from the University of Minnesota. He also holds a surgical research certification from the Academy of Surgical Research.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Eric Solien in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eric Solien works with at each company, as listed on that company's latest Form D.
